Blood and Marrow Transplant Clinical Trials Network Clinical Program Manager Mykala Heuer, BSN, RN, outlines highlights in the agenda, including discussions on operations, empowering coordinators, and changes in study endpoints.
First-line IMM-1-104 plus chemotherapy produced responses and disease control in patients with pancreatic cancer.
Moffitt is taking lung screenings on the road with our new mobile low-dose CT scan, ensuring easy access for eligible individuals in Florida.
It can be difficult to stay active, especially when you aren’t feeling your best. Here, our experts share seven tips for balancing activity and rest…
The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H. Gray Fellow — investing up to…
SSO sponsors educational videoconferences for CGSO Fellows, Residents, and faculty. This session will discuss the management of melanoma in both the localized and metastatic setting.…
Health Canada approved fruquintinib for select patients with metastatic colorectal cancer.
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.
The FDA has granted a breakthrough device designation to the DCISionRT test for patients with breast cancer with ductal carcinoma in situ.
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
